ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink tough lung tumors
Disease control Recruiting nowThis study tests two experimental drugs, ubamatamab and REGN7075, in people with advanced or metastatic non-small cell lung cancer who have already tried standard treatments. The goal is to see if the combination can shrink tumors and control the disease. About 300 participants w…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New drug combo aims to fight advanced lung cancer
Disease control Recruiting nowThis study tests a new medicine called PF-08634404 combined with other cancer drugs in people with advanced non-small cell lung cancer that has spread and cannot be removed by surgery. The goal is to see if the combination is safe and can shrink tumors. About 162 adults will rece…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 11:55 UTC